Showing results (291-300 of 437) with videos related to
Sort By:
Pageof 44
Molecular Cancer Research : MCR|September 24, 2004
Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor typesIan Krop, Audrey Player, Ana Tablante, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcomeYoon-Jae Cho, Aviad Tsherniak, Pablo Tamayo, et al.Cell Reports|November 15, 2018
Trisomy of a Down Syndrome Critical Region Globally Amplifies Transcription via HMGN1 OverexpressionCody T Mowery, Jaime M Reyes, Lucia Cabal-Hierro, et al.Cancer Research|February 5, 2008
Modeling genomic diversity and tumor dependency in malignant melanomaWilliam M Lin, Alissa C Baker, Rameen Beroukhim, et al.Neuro-Oncology Advances|August 21, 2024
Velcrin molecular glues induce apoptosis in glioblastomas with high PDE3A and SLFN12 expressionElisa Aquilanti, Silvia Goldoni, Andrew Baker, et al.Cancer Research|December 20, 2007
PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinibJeffrey A Engelman, Kreshnik Zejnullahu, Christopher-Michael Gale, et al.Blood|February 7, 2008
High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemiaMarc M Loriaux, Ross L Levine, Jeffrey W Tyner, et al.Cancer Research|April 9, 2009
PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFRMartin L Sos, Mirjam Koker, Barbara A Weir, et al.The Journal of Clinical Investigation|March 5, 2014
SOX2 and p63 colocalize at genetic loci in squamous cell carcinomasHideo Watanabe, Qiuping Ma, Shouyong Peng, et al.Nature|October 17, 2008
Activating mutations in ALK provide a therapeutic target in neuroblastomaRani E George, Takaomi Sanda, Megan Hanna, et al.Pageof 44